Next Article in Journal
Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention
Next Article in Special Issue
Asthma and Chronic Rhinosinusitis: Diagnosis and Medical Management
Previous Article in Journal
Sport-Related Concussion: Evaluation, Treatment, and Future Directions
Previous Article in Special Issue
The Role of the Adenoids in Pediatric Chronic Rhinosinusitis
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management

Department of Otorhinolaryngology: Head and Neck Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA
*
Author to whom correspondence should be addressed.
Med. Sci. 2019, 7(3), 45; https://doi.org/10.3390/medsci7030045
Received: 19 January 2019 / Revised: 11 March 2019 / Accepted: 11 March 2019 / Published: 17 March 2019
(This article belongs to the Special Issue Chronic Rhinosinusitis and Concomitant Medical Disorders)
  |  
PDF [1895 KB, uploaded 17 March 2019]
  |  

Abstract

The correlation between aspirin sensitivity, asthma, and nasal polyposis was recognized in the early 20th century. Today, this classic triad of symptoms, eponymously named Samter’s Triad, is known as aspirin exacerbated respiratory disease (AERD). Aspirin exacerbated respiratory disease affects approximately 0.3–0.9% of the general population in the USA and approximately 7% of asthmatic patients. The management of AERD is challenging as no single modality has proven to have high rates of symptom control. Consequently, disease management typically involves a multimodality approach across both medical and surgical disciplines. This review describes the epidemiology of AERD and the current state-of-the-art as it relates to the underlying pathophysiologic mechanisms of this disease process. A significant proportion of the review is focused on the appropriate diagnostic workup for AERD patients including the utility of aspirin provocation testing. The spectrum of medical treatments, including aspirin desensitization and recently introduced immunotherapies, are discussed in detail. Furthermore, surgical approaches to disease control, including advanced endoscopic techniques, are reviewed and treatment outcomes presented. View Full-Text
Keywords: aspirin exacerbated respiratory disease; AERD; Samter’s Triad; chronic rhinosinusitis; endoscopic sinus surgery; aspirin desensitization; nasal polyposis aspirin exacerbated respiratory disease; AERD; Samter’s Triad; chronic rhinosinusitis; endoscopic sinus surgery; aspirin desensitization; nasal polyposis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Li, K.L.; Lee, A.Y.; Abuzeid, W.M. Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management. Med. Sci. 2019, 7, 45.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top